SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ZNTL

Zentalis Pharmaceuticals, Inc.
NASDAQHealth Care

Latest close: 2.13 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 14, 2026Reported purchase · Form 4WALTERS GROUP · $15.2MOpen the filing ↗
  2. Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record52119 flagged findings
Reported transactions (Form 4)67since Feb 1, 2023 · and 11 other holdings
Corporate events (8-K)28since Jul 2, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…requirements with respect thereto; ◦ the timing and amounts of payments from or to our collaborators, licensors and purchasers of…”
    +1 more passage from the same document
    • “…had no indebtedness as of March 31, 2026. ATM Program In May 2021, the Company entered into a sales agreement, or the Sales…”
  • 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗
    “…was $69.5 million of our common stock remaining available for sale under our ATM. Stock Purchase Agreement On December 15, 2025,…”
    +1 more passage from the same document
    • “…Agreement”) with Matrix Capital Master Fund, LP ("Matrix"), one of our then-stockholders. Pursuant to the Stock Purchase…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 521)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 1, 26Form 4 ↗Insider transaction
  • Aug 19, 26SCHEDULE 13G/A ↗Passive stake · Walters William T · 18.8% · event on Aug 14, 26 · amendment
  • Aug 19, 26Form 4 ↗Insider transaction
  • Aug 14, 268-K ↗Current report · Other events
  • Aug 14, 26424B5 ↗Securities offering
  • Aug 13, 26424B5 ↗Securities offering
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Barclays PLC · 3.2% · event on Jun 30, 26 · amendment
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results · Communication to the market
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.2% · event on Jun 30, 26
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Jun 18, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • May 27, 26Form 3 ↗Insider transaction
  • May 27, 26DEFA14A ↗Shareholder meeting and votes
  • May 27, 268-K ↗Current report · A senior executive left or was appointed
  • May 21, 268-K ↗Current report · Communication to the market · Other events
  • May 12, 2610-Q ↗Quarterly report
  • May 12, 268-K ↗Current report · Results · Communication to the market
  • May 5, 268-K ↗Current report · Communication to the market · Other events
  • Apr 30, 26DEFA14A ↗Shareholder meeting and votes

521 filings on record, the oldest from Feb 11, 20.

Listing the 25 most recent filings of the 521 on record.

8-Ks, explained

Stress3Structure5Governance20
  • Governance3 senior executive changes2025 – 2026show all 3hide
    • May 27, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 15, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 26, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 28, 25StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Governance4 senior executive changes2024show all 4hide
    • Dec 19, 24GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • Nov 13, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 29, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 11, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 25, 24StressListing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
  • Oct 6, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 9, 23StructureEntered a material agreement8-K 1.01 ↗
  • Governance6 senior executive changes2022 – 2023show all 6hide
    • Feb 13, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Sep 27, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 12, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 22, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 27, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 31, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 24, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 16, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 8, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 6, 21StructureA material agreement was terminated8-K 1.02 ↗
  • Feb 10, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗

3 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Matrix Capital Management Company, LP10.0%Dec 15, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Walters William T18.8%Aug 14, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • Andrew J. Schwab6.4%Dec 18, 25SCHEDULE 13G ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.2%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
  • Squadron Master Fund LP5.1%Feb 24, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Barclays PLC3.2%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
show one more holderhide
  • Millennium Management LLC1.3%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 14, 26Buy$15.2MWALTERS GROUP↗
  • Feb 10, 26Sell$17KVincent VultaggioPAO and PFO↗
  • Feb 9, 26Sell$2KJULIA MARIE EASTLANDCEO & President↗
  • Feb 9, 26Sell$802Ingmar BrunsChief Medical Officer↗
  • Feb 9, 26Sell$8KVincent VultaggioPAO and PFO↗
  • Feb 6, 26Sell$19KJULIA MARIE EASTLANDCEO & President↗
  • Feb 6, 26Sell$7KIngmar BrunsChief Medical Officer↗
  • Feb 6, 26Sell$73KVincent VultaggioPAO and PFO↗
  • Feb 3, 26Sell$1KVincent VultaggioPAO and PFO↗
  • Feb 2, 26Sell$6KVincent VultaggioPAO and PFO↗
  • Dec 31, 25Buy$7.8MWALTERS GROUP↗
  • Dec 15, 25Sell$10.0MMatrix Capital Management Company, LP↗

There are 10 more transactions in this stretch.

Stock compensation, tax and giftsshow the 18 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Compensation$21KIngmar BrunsChief Medical Officer↗
  • Jun 16, 26Compensationamount n/aScott Dunseth Myers↗
  • Jun 16, 26Compensationamount n/aLuke Nathaniel Walker↗
  • Jun 16, 26Compensationamount n/aDavid Michael Johnson↗
  • Jun 16, 26Compensationamount n/aJan Skvarka↗
  • Jun 16, 26Compensationamount n/aEnoch Kariuki↗
  • May 26, 26Compensationamount n/aShannon Campbell↗
  • Jun 17, 25Compensationamount n/aScott Dunseth Myers↗
  • Jun 17, 25Compensationamount n/aEnoch Kariuki↗
  • Jun 17, 25Compensationamount n/aDavid Michael Johnson↗
  • Jun 17, 25Compensationamount n/aJan Skvarka↗
  • Jun 17, 25Compensationamount n/aLuke Nathaniel Walker↗
  • Feb 3, 25Compensationamount n/aJULIA MARIE EASTLANDCEO & President↗
  • Feb 3, 25Compensationamount n/aIngmar BrunsChief Medical Officer↗
  • Feb 3, 25Compensationamount n/aAndrea PaulChief Legal Officer↗
  • Feb 3, 25Compensationamount n/aMark LacknerChief Scientific Officer↗
  • Feb 3, 25Compensationamount n/aVincent VultaggioPAO and Interim PFO↗
  • Nov 13, 24Compensationamount n/aScott Dunseth Myers↗

The full record holds 98 transactions and goes back to Nov 9, 22.

Its sector and its market

Zentalis Pharmaceuticals, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Zentalis Pharmaceuticals, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Zentalis Pharmaceuticals, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
521 documents on file, from Feb 11, 2020 to Oct 1, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.